Pipeline
Design text placeholder, please provide customer.
Pipeline

Product

Description

Indication

Discovery

Preclinical

IND filing

  • NK-010
  • PBMC-NK

  • 1. Ovarian

    2. Solid

    3. AML

  • NK-011
  • PBMC-Memory NK
  • Tumor

  • NK-042
  • NKR-NK
  • Tumor

  • NK-043
  • NKR-NK
  • Tumor

  • NK-062
  • NKR-NK+
  • Tumor

  • NK-063
  • NKR-NK+
  • Tumor

  • NK-081
  • Bi-NKR/CAR+
  • Tumor

  • NK-082
  • Bi-NKR/CAR+
  • Tumor

  • NK-091
  • Syn-NK+
  • Tumor

  • NK-092
  • Syn-NK+
  • Tumor
NK-010 - Ongoing investigative clinical trials (4 Phase I trails)
Research Center Indication Number of enrollment Progression
Application submission Ethical Approval Start
First Affiliated Hospital of USTC Advanced solid after multi-line therapy (Safety evaluation) 50
Peking University People's Hospital Elderly recurrence (not post-transplant recurrence) or refractory AML 10
First Affiliated Hospital of USTC Ovarian cancer (ascites) 30
First Affiliated Hospital of USTC Solid tumor and hematologic tumor in children (under 18 years old) 30

Telephone:021-50888199

Email: contact@nk-celltech.com

Our location:Building 7, Lane 100, Banxia Road, Zhoupu Town, Pudong New Area, Shanghai

WeChat

© Copyright by CSPC All rights reserved. ICP备字：沪ICP备2022013361号-1

Legal statement Privacy Policy Terms Of Use